Optimer Pharmaceuticals, Inc. (OPTR)

[invest2win]

Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) should be getting shredded today, after Friday's bearish outside day reversal - that's usually a real killer for small cap stocks that trade this thinly. Yet, here we are, with OPTR not only blowing off Friday's high-volume selloff, but on track to finish the day above where it left off Thursday (totally negating Friday's implosion), and poised to do so on higher volume than we saw behind Friday's implosion. Simply put, that was the best shot the bears had at knocking OPTR down once and for all, and they just couldn't do it. Maybe it's got something to do with the fact that Optimer Pharmaceuticals is a $643 million company that now has a real and marketable drug to treat intestinal infections - a market that could be worth at least the same amount.

http://www.smallcapnetwork.com/Reading-the-Tea-Leaves-for-RUTH-OPTR-and-EEE/s/via/1789/article/view/p/mid/1/id/10/